☆ 4.8 Article

The influence of methotrexate-related transporter and metabolizing enzyme gene polymorphisms on peri-engraftment syndrome and graft-versus-host disease after haplo-hematopoietic stem cell transplantation in pediatric patients with malignant hematological diseases

FRONTIERS IN IMMUNOLOGY (2023)

Related references

Note: Only part of the references are listed.

Review Pharmacology & Pharmacy

Association between high-dose methotrexate-induced toxicity and polymorphisms within methotrexate pathway genes in acute lymphoblastic leukemia

Meng Xu et al.

Summary: High-dose methotrexate (HD-MTX) is an effective chemotherapy drug for children with acute lymphoblastic leukemia (ALL), but its toxicity is influenced by gene polymorphisms in the MTX metabolic pathway. The association of SLCO1B1 and ARID5B gene polymorphisms with MTX and MTX-related toxicity has been clearly described and should be evaluated before treatment.

FRONTIERS IN PHARMACOLOGY (2022)

Add to Collection

Article Pharmacology & Pharmacy

Effects of SLCO1B1 on elimination and toxicities of high-dose methotrexate in pediatric acute lymphoblastic leukemia

Fei-Fei Yang et al.

Summary: SLCO1B1 polymorphisms are associated with the elimination and toxicities of high-dose MTX, providing potential benefits for optimizing MTX therapy in patients.

PHARMACOGENOMICS (2022)

Add to Collection

Review Oncology

Engraftment syndrome following Hematopoietic stem cell transplantation: a systematic approach toward diagnosis and management

Shahzaib Maqbool et al.

Summary: Engraftment syndrome (ES) is a common non-infectious complication in hematopoietic stem cell transplants, characterized by fever, diarrhea, and skin rash. ES has a high incidence and is often treated with intravenous methylprednisolone.

MEDICAL ONCOLOGY (2022)

Add to Collection

Article Medicine, Research & Experimental

Effect ofSLCO1B1Polymorphisms on High-Dose Methotrexate Clearance in Children and Young Adults With Leukemia and Lymphoblastic Lymphoma

Rachael R. Schulte et al.

Summary: High-dose methotrexate is a critical treatment component for hematologic malignancies in children and young adults. This study found that patient weight and SLCO1B1 genotype significantly influence MTX clearance variability, highlighting the importance of considering these factors in personalized dosing of high-dose MTX.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)

Add to Collection

Article Oncology

Effect of Polymorphisms of ABCB1 and MTHFR on Methotrexate-Related Toxicities in Adults With Hematological Malignancies

Jian Han et al.

Summary: The study showed that SNPs of MTHFR and ABCB1 are associated with MTX-related hematopoietic toxicity in adults with hematological malignancies. It is necessary to detect these SNPs before starting high-dose MTX therapy to determine the optimal dose of MTX and leucovorin rescue duration.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Inflammatory monocytes promote pre-engraftment syndrome and tocilizumab can therapeutically limit pathology in patients

Linlin Jin et al.

Summary: Unrelated cord blood transplantation is effective for hematopoietic disorders but often leads to pre-engraftment syndrome (PES). GM-CSF produced by cord blood-derived inflammatory monocytes drives PES pathology, and tocilizumab has shown clinical efficacy in limiting pathology in PES patients. This study provides insights into the pathogenesis and treatment of PES, improving nonrelapse mortality outcomes.

NATURE COMMUNICATIONS (2021)

Add to Collection

Review Oncology

Systematic Review of Pharmacogenetic Factors That Influence High-Dose Methotrexate Pharmacokinetics in Pediatric Malignancies

Zachary L. Taylor et al.

Summary: High-dose methotrexate is commonly used in cancer treatment, but its variability in elimination can lead to serious adverse events. While many studies have looked into how genetic factors influence methotrexate elimination, conflicting results and lack of replication and validation have hindered progress. Despite identifying some genes affecting methotrexate clearance, more research is needed to confirm their effects and improve patient outcomes.

CANCERS (2021)

Add to Collection

Article Hematology

Role of folinic acid in methotrexate-based prophylaxis of graft-versus-host disease following hematopoietic stem cell transplantation

Naif AlJohani

Summary: Methotrexate is commonly used to prevent GvHD after stem cell transplantation, but its toxicity and side effects often lead to dose reductions or early withdrawal, increasing the risk of GvHD and graft failure. Folinic acid can help reduce MTX toxicity, but concerns about its impact on MTX's anti-GvHD effect and limited clinical reports have hindered its widespread use.

HEMATOLOGY (2021)

Add to Collection

Article Hematology

Risk factors and appropriate therapeutic strategies for thrombotic microangiopathy after allogeneic HSCT

Hiroyuki Matsui et al.

BLOOD ADVANCES (2020)

Add to Collection

Article Biochemistry & Molecular Biology

ABCB1 (C1236T) Polymorphism Affects P-Glycoprotein-Mediated Transport of Methotrexate, Doxorubicin, Actinomycin D, and Etoposide

Bo Jiang et al.

DNA AND CELL BIOLOGY (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Current Advances in Studying Clinically Relevant Transporters of the Solute Carrier (SLC) Family by Connecting Computational Modeling and Data Science

Alzbeta Tuerkova et al.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2019)

Add to Collection

Article Oncology

SLCO1B1 Polymorphisms are Associated With Drug Intolerance in Childhood Leukemia Maintenance Therapy

Irem Eldem et al.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2018)

Add to Collection

Article Pediatrics

Graft-versus-host disease (GVHD) prophylaxis by using methotrexate decreases pre-engraftment syndrome and severe acute GVHD, and accelerates engraftment after cord blood transplantation

Akihiro Iguchi et al.

PEDIATRIC TRANSPLANTATION (2016)

Add to Collection

Article Hematology

International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium

Andrew C. Harris et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)

Add to Collection

Article Oncology

Genetic polymorphisms predicting methotrexate blood levels and toxicity in adult non-Hodgkin lymphoma

Irit Avivi et al.

LEUKEMIA & LYMPHOMA (2014)

Add to Collection

Article Biotechnology & Applied Microbiology

Influence of the folate pathway and transporter polymorphisms on methotrexate treatment outcome in osteosarcoma

Katja Goricar et al.

PHARMACOGENETICS AND GENOMICS (2014)

Add to Collection

Review Pharmacology & Pharmacy

Genetic polymorphisms in low-dose methotrexate transporters: current relevance as methotrexate therapeutic outcome biomarkers

Aurea Lima et al.

PHARMACOGENOMICS (2014)

Add to Collection

Article Hematology

Pre-Engraftment Syndrome after Unrelated Cord Blood Transplantation: A Predictor of Engraftment and Acute Graft-versus-Host Disease

Meerim Park et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)

Add to Collection

Article Hematology

Genome-wide study of methotrexate clearance replicates SLCO1B1

Laura B. Ramsey et al.

BLOOD (2013)

Add to Collection

Article Hematology

Germline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity, and outcome in childhood acute lymphoblastic leukemia

Susanne Radtke et al.

BLOOD (2013)

Add to Collection

Article Biophysics

Peri-engraftment syndrome in allogeneic hematopoietic SCT

K. T. Hong et al.

BONE MARROW TRANSPLANTATION (2013)

Add to Collection

Article Oncology

Polymorphisms of the SLCO1B1 Gene Predict Methotrexate-Related Toxicity in Childhood Acute Lymphoblastic Leukemia

Elixabet Lopez-Lopez et al.

PEDIATRIC BLOOD & CANCER (2011)

Add to Collection

Article Oncology

Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial

Birte Friedrichs et al.

LANCET ONCOLOGY (2010)

Add to Collection

Article Oncology

Germline Genetic Variation in an Organic Anion Transporter Polypeptide Associated With Methotrexate Pharmacokinetics and Clinical Effects

Lisa R. Trevin et al.

JOURNAL OF CLINICAL ONCOLOGY (2009)

Add to Collection

Article Biophysics

Short-term methotrexate could reduce early immune reactions and improve outcomes in umbilical cord blood transplantation for adults

H. Narimatsu et al.

BONE MARROW TRANSPLANTATION (2007)

Add to Collection

Article Biotechnology & Applied Microbiology

Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene

DL Kroetz et al.

PHARMACOGENETICS (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.